BSE Live
Oct 06, 16:01Prev. Close
2402.65
Open Price
2380.55
Bid Price (Qty.)
2415.00 (10)
Offer Price (Qty.)
2438.00 (16)
NSE Live
Oct 06, 15:57Prev. Close
2401.80
Open Price
2401.90
Bid Price (Qty.)
2431.30 (4)
Offer Price (Qty.)
0.00 (0)
Balance Sheet of Ajanta Pharma (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
EQUITIES AND LIABILITIES | ||||||
SHAREHOLDER'S FUNDS | ||||||
Equity Share Capital | 25.07 | 25.27 | 25.27 | 17.17 | 17.39 | |
Total Share Capital | 25.07 | 25.27 | 25.27 | 17.17 | 17.39 | |
Reserves and Surplus | 3,765.22 | 3,536.44 | 3,362.38 | 3,247.17 | 2,978.24 | |
Total Reserves and Surplus | 3,765.22 | 3,536.44 | 3,362.38 | 3,247.17 | 2,978.24 | |
Total Shareholders Funds | 3,790.29 | 3,567.36 | 3,387.99 | 3,264.34 | 2,995.63 | |
Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
NON-CURRENT LIABILITIES | ||||||
Long Term Borrowings | 0.00 | 0.00 | 1.25 | 1.64 | 1.60 | |
Deferred Tax Liabilities [Net] | 110.52 | 108.50 | 97.72 | 101.87 | 92.17 | |
Other Long Term Liabilities | 37.77 | 27.23 | 28.63 | 21.02 | 22.76 | |
Long Term Provisions | 80.27 | 39.54 | 24.15 | 19.32 | 17.93 | |
Total Non-Current Liabilities | 228.56 | 175.27 | 151.75 | 143.85 | 134.46 | |
CURRENT LIABILITIES | ||||||
Short Term Borrowings | 2.59 | 1.49 | 0.18 | 0.27 | 0.00 | |
Trade Payables | 454.20 | 463.20 | 422.77 | 327.17 | 373.86 | |
Other Current Liabilities | 515.96 | 413.31 | 702.31 | 309.14 | 263.06 | |
Short Term Provisions | 23.35 | 17.76 | 14.02 | 10.81 | 11.71 | |
Total Current Liabilities | 996.10 | 895.76 | 1,139.28 | 647.39 | 648.63 | |
Total Capital And Liabilities | 5,014.95 | 4,638.39 | 4,679.02 | 4,055.58 | 3,778.72 | |
ASSETS | ||||||
NON-CURRENT ASSETS | ||||||
Tangible Assets | 1,715.50 | 1,464.53 | 1,488.69 | 1,502.97 | 1,530.32 | |
Intangible Assets | 46.52 | 14.66 | 7.75 | 9.02 | 10.79 | |
Capital Work-In-Progress | 176.27 | 256.45 | 209.47 | 152.86 | 108.19 | |
Fixed Assets | 1,938.29 | 1,735.64 | 1,705.91 | 1,664.85 | 1,649.30 | |
Non-Current Investments | 25.24 | 18.58 | 25.10 | 25.10 | 0.00 | |
Deferred Tax Assets [Net] | 186.43 | 134.45 | 96.77 | 55.55 | 50.10 | |
Long Term Loans And Advances | 0.00 | 0.00 | 0.00 | 0.00 | 6.47 | |
Other Non-Current Assets | 21.96 | 18.80 | 17.24 | 45.62 | 45.26 | |
Total Non-Current Assets | 2,171.92 | 1,907.47 | 1,845.02 | 1,791.12 | 1,751.13 | |
CURRENT ASSETS | ||||||
Current Investments | 438.71 | 330.05 | 510.27 | 121.86 | 175.67 | |
Inventories | 903.85 | 828.36 | 815.63 | 791.07 | 766.47 | |
Trade Receivables | 1,182.74 | 1,246.84 | 1,056.90 | 1,019.81 | 738.43 | |
Cash And Cash Equivalents | 176.24 | 130.77 | 330.90 | 211.79 | 209.61 | |
Short Term Loans And Advances | 2.54 | 33.96 | 17.39 | 6.37 | 8.03 | |
OtherCurrentAssets | 138.95 | 160.94 | 102.91 | 113.56 | 129.38 | |
Total Current Assets | 2,843.03 | 2,730.92 | 2,834.00 | 2,264.46 | 2,027.59 | |
Total Assets | 5,014.95 | 4,638.39 | 4,679.02 | 4,055.58 | 3,778.72 | |
OTHER ADDITIONAL INFORMATION | ||||||
CONTINGENT LIABILITIES, COMMITMENTS | ||||||
Contingent Liabilities | 144.28 | 161.39 | 91.52 | 76.44 | 168.98 | |
BONUS DETAILS | ||||||
Bonus Equity Share Capital | 15.50 | 15.63 | 15.63 | 7.09 | 7.09 | |
NON-CURRENT INVESTMENTS | ||||||
Non-Current Investments Quoted Market Value | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Non-Current Investments Unquoted Book Value | 25.24 | 18.58 | 0.00 | 0.00 | 0.00 | |
CURRENT INVESTMENTS | ||||||
Current Investments Quoted Market Value | 428.59 | 299.15 | 510.27 | 121.86 | 138.99 | |
Current Investments Unquoted Book Value | 0.00 | 0.00 | 0.00 | 0.00 | 36.68 |
22.09.2025
01.08.2025
29.07.2025
Ajanta Pharma Consolidated June 2025 Net Sales at Rs 1,302.65 crore, up 13.78% Y-o-Y
29.07.2025
Ajanta Pharma Standalone June 2025 Net Sales at Rs 1,208.56 crore, up 12.19% Y-o-Y
29.07.2025
Ajanta Pharma Consolidated June 2025 Net Sales at Rs 1,302.65 crore, up 13.78% Y-o-Y
29.07.2025
Ajanta Pharma Standalone June 2025 Net Sales at Rs 1,208.56 crore, up 12.19% Y-o-Y
02.05.2025
Ajanta Pharma Consolidated March 2025 Net Sales at Rs 1,170.41 crore, up 11.04% Y-o-Y
02.05.2025
Ajanta Pharma Standalone March 2025 Net Sales at Rs 1,013.94 crore, up 9.49% Y-o-Y
12.07.2023
Ajanta Pharma Q1 PAT seen up 9.1% YoY to Rs 190.5 cr: Nirmal Bang
13.07.2022
Ajanta Pharma Q1 PAT may dip 12.7% YoY to Rs 151.6 cr: ICICI Direct
11.01.2019
Ajanta Pharma Q3 PAT may dip 35.1% YoY to Rs. 95.8 cr: ICICI Direct
12.10.2018
Ajanta Pharma Q2 PAT may dip 16.5% YoY to Rs. 110.1 cr: ICICI Direct